LeMaitre Vascular, Inc. (LMAT) Q4 2010 Earnings Results

Lemaitre Vascular Misses on Revenue, Stock Down 2.47%

The lack of detailed revenue figures and guidance may raise concerns among investors about the company's future performance. The stock's decline of 2.47% reflects market uncertainty following the earnings report. Investors will likely be looking for more clarity in upcoming communications from the company.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.13	N/A	N/A
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Neutral

Management emphasized their commitment to operational efficiency. However, they did not provide specific guidance or insights into future revenue expectations.

Management did not provide specific revenue figures or guidance for the upcoming period.

The focus remains on maintaining operational efficiency and product development.

Lemaitre Vascular Misses on Revenue, Stock Down 2.47%

Key numbers

Management commentary

LeMaitre Vascular, Inc.

More earnings this week

Lemaitre Vascular Misses on Revenue, Stock Down 2.47%

Key numbers

Management commentary